IL188843A0 - Bicyclic 6-alkylidene-penem b-lactamase inhibitors and ??-lactam antibiotic combination: a broad spectrum antibiotic - Google Patents

Bicyclic 6-alkylidene-penem b-lactamase inhibitors and ??-lactam antibiotic combination: a broad spectrum antibiotic

Info

Publication number
IL188843A0
IL188843A0 IL188843A IL18884308A IL188843A0 IL 188843 A0 IL188843 A0 IL 188843A0 IL 188843 A IL188843 A IL 188843A IL 18884308 A IL18884308 A IL 18884308A IL 188843 A0 IL188843 A0 IL 188843A0
Authority
IL
Israel
Prior art keywords
penem
alkylidene
bicyclic
antibiotic
broad spectrum
Prior art date
Application number
IL188843A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of IL188843A0 publication Critical patent/IL188843A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL188843A 2005-07-27 2008-01-17 Bicyclic 6-alkylidene-penem b-lactamase inhibitors and ??-lactam antibiotic combination: a broad spectrum antibiotic IL188843A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70280905P 2005-07-27 2005-07-27
PCT/US2006/028948 WO2007016134A1 (en) 2005-07-27 2006-07-26 BICYCLIC 6-ALKYLIDENE-PENEM B-LACTAMASE INHIBITORS AND β-LACTAM ANTIBIOTIC COMBINATION: A BROAD SPECTRUM ANTIBIOTIC

Publications (1)

Publication Number Publication Date
IL188843A0 true IL188843A0 (en) 2008-08-07

Family

ID=37110353

Family Applications (1)

Application Number Title Priority Date Filing Date
IL188843A IL188843A0 (en) 2005-07-27 2008-01-17 Bicyclic 6-alkylidene-penem b-lactamase inhibitors and ??-lactam antibiotic combination: a broad spectrum antibiotic

Country Status (18)

Country Link
US (1) US20070129344A1 (OSRAM)
EP (1) EP1906954A1 (OSRAM)
JP (1) JP2009502934A (OSRAM)
KR (1) KR20080032637A (OSRAM)
CN (1) CN101232881A (OSRAM)
AR (1) AR055096A1 (OSRAM)
AU (1) AU2006275940A1 (OSRAM)
BR (1) BRPI0613927A2 (OSRAM)
CA (1) CA2615886A1 (OSRAM)
CR (1) CR9691A (OSRAM)
EC (1) ECSP088132A (OSRAM)
GT (1) GT200600331A (OSRAM)
IL (1) IL188843A0 (OSRAM)
NO (1) NO20080314L (OSRAM)
PE (1) PE20070403A1 (OSRAM)
RU (1) RU2008102912A (OSRAM)
TW (1) TW200727897A (OSRAM)
WO (1) WO2007016134A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
US20090018332A1 (en) * 2007-06-28 2009-01-15 Wyeth Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors
CN103435617B (zh) * 2013-08-22 2016-04-27 南京华安药业有限公司 一种6,7-二氢-5H-吡咯并[1,2-a]咪唑-2-甲醛的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206067A (en) * 1978-10-02 1980-06-03 Chevron Research Company Thermally stabilized erosion-inhibited functional fluids containing perhalometal compounds and an organic base
EP0041768B1 (en) * 1980-04-24 1987-11-11 Beecham Group Plc Beta-lactam compounds, their preparation and use
US4891369A (en) * 1986-12-03 1990-01-02 Taiho Pharmaceutical Company, Limited 2β-Substituted-methylpenicillanic acid derivatives, and salts and esters thereof
NZ237202A (en) * 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
WO1995028935A1 (en) * 1994-04-25 1995-11-02 Smithkline Beecham Plc Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
EA200100347A1 (ru) * 1998-10-15 2001-10-22 Саравак Медичем Фармасьютикалс, Инк. Метод и композиция для лечения и профилактики туберкулеза
GB9928290D0 (en) * 1999-12-01 2000-01-26 Univ Belfast Process for preparing ambient temperature ionic liquids
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
AR046041A1 (es) * 2003-10-03 2005-11-23 Aventis Pharma Inc Procedimiento para la preparacion de compuestos heterociclicos n-amino sustituidos

Also Published As

Publication number Publication date
GT200600331A (es) 2007-02-26
BRPI0613927A2 (pt) 2011-02-15
CR9691A (es) 2008-04-02
KR20080032637A (ko) 2008-04-15
JP2009502934A (ja) 2009-01-29
TW200727897A (en) 2007-08-01
CN101232881A (zh) 2008-07-30
PE20070403A1 (es) 2007-05-15
ECSP088132A (es) 2008-03-26
US20070129344A1 (en) 2007-06-07
NO20080314L (no) 2008-04-22
RU2008102912A (ru) 2009-09-10
WO2007016134A9 (en) 2009-03-12
EP1906954A1 (en) 2008-04-09
AR055096A1 (es) 2007-08-08
CA2615886A1 (en) 2007-02-08
WO2007016134A1 (en) 2007-02-08
AU2006275940A1 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
IL179398A0 (en) Dpp-ib inhibitors
IL178104A0 (en) Inhibitors of iap
IL179854A0 (en) Inhibitors of iap
IL178807A0 (en) Factor xa inhibitors
IL185185A0 (en) Azolylacylguanidines as ??-secretase inhibitors
ZA200610771B (en) Quinazolinedolone derivatives as PARP inhibitors
IL191997A0 (en) Inhibitors of iap
IL191987A0 (en) Heterocyclyacrylamide compounds as fabi inhibitors and antibacterial agents
EP2209474A4 (en) BROAD SPECTRUM BETA-LACTAMASE INHIBITORS
IL177037A (en) Kimase inhibitors
IL179305A0 (en) Dpp-iv inhibitors
IL199427A (en) Radiation-protective compounds and related methods
GB0421355D0 (en) Inhibitors
EP1789055A4 (en) INHIBITORS OF THIAZOLOPYRIDINE KINASE
GB0515327D0 (en) Comt inhibitors
GB0421356D0 (en) Inhibitors
EP1870412A4 (en) 2-THIOETHENYLCARBAPENEM DERIVATIVE
HK1115065A (en) BICYCLIC 6-ALKYLIDENE-PENEM B-LACTAMASE INHIBITORS AND β-LACTAM ANTIBIOTIC COMBINATION: A BROAD SPECTRUM ANTIBIOTIC
SG123660A1 (en) Spanner
GB0516967D0 (en) Inhibitors
AU2004901478A0 (en) SGLTs inhibitors
HK1103400A (zh) Parp抑制剂
GB0405975D0 (en) Any tool trigger time recorder
AU156944S (en) Fluid-operated wrench
AU2005906482A0 (en) Heparanase Inhibitors